Clinical Trial Update: AT-007 in Adult Subjects With Classic Galactosemia (CG) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for AT-007 in adults with Classic Galactosemia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classic Galactosemia

Drugs mentioned

• AT 007

Snippet

Sponsor: Applied Therapeutics, Inc. | Conditions: Classic Galactosemia | Phase 3 | Status: UNKNOWN